A Pharmacokinetics and Safety Study in Subjects With Renal Impairment

NCT01452828 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: TR-701 FA single infusion
DRUG: TR-701 FA
DRUG: TR-701 FA

Sponsor

Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)